Source: Matt Talhelm, WRAL, 12/3/21

 Biomedical engineers at Duke University have devised a test to quickly and easily assess how well someone's antibodies fight infection from multiple coronavirus variants. The test, dubbed the COVID-19 Variant Spike-ACE2-Competitive Antibody Neutralization assay, or CoVariant-SCAN, could potentially tell doctors how protected a patient is from variants circulating in a community as well as new ones. It also could indicate which monoclonal antibody treatments would best help a patient.

For more of this story, click here.